stockrowSTERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.
- Revenue
- +8.79%
- EPS
- +12.8%
- Free cash flow
- +43.6%
- Total debt
- −0.21%
Quarter to September 2026, against a year earlier
Follow STE
Alert me
STERIS plc (STE) Net income
STERIS plc's net income for fiscal 2026 was $785.1M, up 27.4% from $616.1M in fiscal 2025. Over the twelve months to 30 September 2026 it was $829.8M. Over the past ten years it has ranged from $105.8M (fiscal 2023) to $785.1M (fiscal 2026) — the current reading is the highest in ten years. Net income has risen for 3 consecutive fiscal years. STERIS plc ranks 10th of 149 Medical Devices companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2026 | $785.1M | 27.43% |
| FY2025 | $616.1M | 62.09% |
| FY2024 | $380.1M | 259.22% |
| FY2023 | $105.8M | (56.43%) |
| FY2022 | $242.9M | (38.80%) |
| FY2021 | $396.9M | (2.69%) |
| FY2020 | $407.9M | 33.84% |
| FY2019 | $304.7M | 4.50% |
| FY2018 | $291.6M | 163.60% |
| FY2017 | $110.6M | (0.85%) |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $214.1M | 6.52% |
| Jun 2026 | $201.0M | (8.76%) |
| Mar 2026 | $220.3M | 13.32% |
| Dec 2025 | $194.4M | 1.04% |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| GEHC GE HealthCare Technologies Inc. compare | $2.2B |
| SNN Smith & Nephew SNATS, Inc. compare | $2.0B |
| PHG Koninklijke Philips N.V. compare | $1.1B |
| DXCM DexCom, Inc. compare | $991.0M |
| STE STERIS plc | $829.8M |
| ZBH Zimmer Biomet Holdings, Inc. compare | $768.8M |
| GMED Globus Medical, Inc. compare | $557.6M |
| PEN Penumbra, Inc. compare | $157.0M |
| GKOS Glaukos Corporation compare | −$169.8M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on STE
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement